Slides to Guide Management of Patients With HCV/HIV Coinfection

Gain expert perspective on selecting optimal DAA and ARV combinations for patients with HCV/HIV coinfection in this downloadable slideset.
Mark S. Sulkowski, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 327 KB
Released: July 20, 2018

Acknowledgements

Jointly provided by Postgraduate Institute for Medicine and Clinical Care Options, LLC
PIM Logo

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an independent educational grant from
Gilead Sciences

Related Content

Expert insight on the burden and impact of HBV infection, as well as strategies to overcome barriers to vaccination, from Clinical Care Options (CCO)

Robert G. Gish, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: March 22, 2022 Expired: March 21, 2023

Expert commentary on addressing barriers to vaccine uptake in older individuals, from Dr Barbara Resnick and Clinical Care Options (CCO)

Barbara Resnick, PhD, CRNP Released: January 12, 2022

Listen to expert insights from Martin C. Mahoney, MD, PhD, on new data for vaccine-preventable diseases presented at the IDWeek meeting, including pneumococcal disease, respiratory syncytial virus, herpes zoster, and influenza.

Martin C. Mahoney, MD, PhD Released: December 6, 2021

Clinical Care Options (CCO): Dr. Paul Auwaerter discusses the latest pneumococcal vaccine data and the impact on his practice, presented at IDWeek 2021

Paul G. Auwaerter, MD Released: November 19, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings